Alzheimer's dementia. Alzheimer's disease
Conditions
Interventions
Intervention 1: Intervention group: Patients with entry criteria who have symptoms of agitation or aggression. These patients are treated with Quetiapine(Abidi company) and during 2-4 weeks, the dose
Sponsors
University of social welfare and rehabilitation sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adult patients (over the age of 18) With Alzheimer's dementia At least two years have passed since the onset of the disease Confirm by a neurologist or psychiatrist with the NIA-AA (2011 National Institute on Aging and Alzheimer's Association) diagnostic criteria assistant. Participant's consent Cohen-Mansfield Agitation Inventory (CMAI) test score more than 45
Exclusion criteria
Exclusion criteria: No psychiatric disability No physical disability No neurological disability Any disease with significant cognitive Impairment, (mental retardation) No substance abuse in the previous six months No extra psychiatric medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -Cognitive changes by the MMSE - symptoms of agitation and aggression by the CMAI. Timepoint: In 0,4,6 weeks. Method of measurement: Questionnaire Mini–mental state examination(MMSE) ,Questionnaire Cohen Mansfield Agitation Inventory(CMAI). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSahar Darvishskandari
University of social welfare and rehabilitation sciences
Outcome results
None listed